Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 10851-10900 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04880031
A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension
PHASE2Active, not recruiting
231 participants
Started: Sep 30, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors48 locations
NCT04985760
Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy
PHASE1Active, not recruiting
32 participants
Started: Sep 30, 2021 · Completed: Nov 28, 2025
1 condition2 sponsors2 locations
NCT05065593
The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis
NAActive, not recruiting
26 participants
Started: Sep 30, 2021 · Completed: Jan 30, 2025
1 condition1 sponsor1 location
NCT05321407
COVID-19 Vaccine Responses in PIDD Subjects
N/AActive, not recruiting
100 participants
Started: Sep 30, 2021 · Completed: Jul 31, 2026
7 conditions5 sponsors3 locations
NCT04904588
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
PHASE2Active, not recruiting
300 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
8 conditions2 sponsors39 locations
NCT04828382
Prospective Study of Pregnancy in Women with Cystic Fibrosis
N/AActive, not recruiting
285 participants
Started: Sep 30, 2021 · Completed: Dec 30, 2026
2 conditions4 sponsors40 locations
NCT04965090
A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)
PHASE2Active, not recruiting
43 participants
Started: Sep 30, 2021 · Completed: Jul 31, 2026
2 conditions2 sponsors7 locations
NCT04987138
Safety and Effectiveness Study of the Zenflow Spring System
NAActive, not recruiting
279 participants
Started: Sep 30, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor7 locations
NCT04977765
Cardiometabolic Health in Transgender Males
N/AActive, not recruiting
90 participants
Started: Sep 30, 2021 · Completed: Aug 1, 2027
2 conditions2 sponsors1 location
NCT04704674
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
N/AActive, not recruiting
396 participants
Started: Sep 30, 2021 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05054140
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
PHASE2Active, not recruiting
450 participants
Started: Sep 30, 2021 · Completed: Jan 7, 2025
1 condition1 sponsor73 locations
NCT04822246
Root Caries Excavation with Air Water/powder Prophylaxis Device for ART Restorations
NAActive, not recruiting
62 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04973683
AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer
PHASE1Active, not recruiting
14 participants
Started: Sep 30, 2021 · Completed: Dec 15, 2025
2 conditions1 sponsor1 location
NCT05019976
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
NAActive, not recruiting
30 participants
Started: Sep 30, 2021 · Completed: Dec 1, 2027
3 conditions1 sponsor1 location
NCT04635228
Biodesign® Otologic Repair Graft
N/AActive, not recruiting
87 participants
Started: Sep 29, 2021 · Completed: Oct 31, 2026
2 conditions1 sponsor5 locations
NCT06284213
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
N/AActive, not recruiting
1,892 participants
Started: Sep 29, 2021 · Completed: Jul 31, 2027
2 conditions18 sponsors17 locations
NCT06196684
Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
N/AActive, not recruiting
30 participants
Started: Sep 29, 2021 · Completed: Oct 30, 2026
2 conditions1 sponsor1 location
NCT04975919
Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE2Active, not recruiting
20 participants
Started: Sep 29, 2021 · Completed: May 31, 2026
4 conditions1 sponsor1 location
NCT04997499
Adolescent Subcutaneous (SQ) Injection Video Validation
NAActive, not recruiting
30 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05043220
Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy
NAActive, not recruiting
100 participants
Started: Sep 29, 2021 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT04908813
Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer
PHASE2Active, not recruiting
150 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05059522
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
PHASE3Active, not recruiting
68 participants
Started: Sep 29, 2021 · Completed: Sep 30, 2026
5 conditions1 sponsor68 locations
NCT04940286
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer
PHASE2Active, not recruiting
13 participants
Started: Sep 28, 2021 · Completed: Oct 30, 2027
6 conditions1 sponsor1 location
NCT04716725
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer
PHASE2Active, not recruiting
15 participants
Started: Sep 28, 2021 · Completed: Apr 30, 2025
5 conditions4 sponsors1 location
NCT04588883
Strengthening Families Living With HIV in Kenya
NAActive, not recruiting
843 participants
Started: Sep 28, 2021 · Completed: Aug 15, 2025
6 conditions1 sponsor1 location
NCT05273996
Predictors of Cognitive Outcomes in Geriatric Depression
PHASE4Active, not recruiting
75 participants
Started: Sep 28, 2021 · Completed: Jun 30, 2026
4 conditions2 sponsors1 location
NCT04831320
Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor
PHASE2Active, not recruiting
46 participants
Started: Sep 28, 2021 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04985851
To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
NAActive, not recruiting
90 participants
Started: Sep 28, 2021 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT05022849
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
PHASE1Active, not recruiting
15 participants
Started: Sep 28, 2021 · Completed: Oct 30, 2037
1 condition1 sponsor8 locations
NCT04936308
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
PHASE3Active, not recruiting
453 participants
Started: Sep 28, 2021 · Completed: Jul 16, 2026
1 condition1 sponsor169 locations
NCT04931654
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer
PHASE1/PHASE2Active, not recruiting
136 participants
Started: Sep 28, 2021 · Completed: Aug 12, 2026
3 conditions1 sponsor21 locations
NCT04993625
Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy In HER-2 Positive/Triple Negative Breast Cancer Patients With Excellent Radiologic Response to the Breast and Axilla, Prospective, Multi-center, Single-arm (ASLAN) Study
NAActive, not recruiting
178 participants
Started: Sep 27, 2021 · Completed: Dec 31, 2028
1 condition5 sponsors1 location
NCT04728633
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases
PHASE2Active, not recruiting
28 participants
Started: Sep 27, 2021 · Completed: Jun 30, 2027
3 conditions1 sponsor1 location
NCT04953780
2157GCCC:Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Dx AML
PHASE1Active, not recruiting
6 participants
Started: Sep 27, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT04840511
The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping
NAActive, not recruiting
60 participants
Started: Sep 27, 2021 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT04884815
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
PHASE1/PHASE2Active, not recruiting
82 participants
Started: Sep 27, 2021 · Completed: Mar 31, 2034
1 condition1 sponsor17 locations
NCT04874480
Tegavivint for the Treatment of Relapsed or Refractory Leukemia
PHASE1Active, not recruiting
9 participants
Started: Sep 27, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05215548
Primary Tumor Resection With EGFR TKI for Stage IV NSCLC
PHASE2Active, not recruiting
100 participants
Started: Sep 27, 2021 · Completed: Oct 31, 2027
1 condition1 sponsor2 locations
NCT04731077
Avenir Complete Post-Market Clinical Follow-Up Study
NAActive, not recruiting
275 participants
Started: Sep 27, 2021 · Completed: Jun 1, 2036
4 conditions1 sponsor9 locations
NCT05367024
Broccoli Effect on Glycated Haemoglobin (HbA1c)
NAActive, not recruiting
26 participants
Started: Sep 27, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05447767
Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg (PATTERN)
NAActive, not recruiting
240 participants
Started: Sep 27, 2021 · Completed: May 29, 2025
1 condition3 sponsors1 location
NCT04984486
In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Bone Level
N/AActive, not recruiting
138 participants
Started: Sep 27, 2021 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT04850300
Efficiency Assessment of the Methodology for the Follow-up of Patients With Knee Prostheses
PHASE3Active, not recruiting
99 participants
Started: Sep 27, 2021 · Completed: Jul 31, 2024
1 condition2 sponsors2 locations
NCT05010694
GH35 Tablets for Advanced Solid Tumors: A Study on Safety and Early Results
PHASE1Active, not recruiting
18 participants
Started: Sep 27, 2021 · Completed: Dec 12, 2025
1 condition1 sponsor2 locations
NCT04765241
mHealth Physical Activity Intervention for Young Cancer Survivors
NAActive, not recruiting
287 participants
Started: Sep 27, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT04826562
Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)
PHASE4Active, not recruiting
40 participants
Started: Sep 26, 2021 · Completed: Dec 30, 2023
1 condition2 sponsors1 location
NCT05051696
Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies
PHASE2Active, not recruiting
120 participants
Started: Sep 26, 2021 · Completed: Mar 30, 2025
1 condition1 sponsor1 location
NCT04254627
TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset
PHASE1Active, not recruiting
20 participants
Started: Sep 24, 2021 · Completed: Sep 30, 2025
1 condition3 sponsors2 locations
NCT04767984
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
PHASE2Active, not recruiting
42 participants
Started: Sep 24, 2021 · Completed: Nov 30, 2026
2 conditions2 sponsors3 locations
NCT05565287
Neonatal Neurobehavioral And Motor Behavior In Ultra Early Physical Therapy Intervention
EARLY_PHASE1Active, not recruiting
80 participants
Started: Sep 24, 2021 · Completed: Dec 30, 2025
3 conditions1 sponsor3 locations